Read this company snapshot
Daily valuation snapshot
Emmis Acquisition Corp. Class A Ordinary Shares: source evidence dated 2026-09-25.
- Daily close (USD)
- $10.27
- Market capitalization (USD)
- $39,368,329.91
- Price / earnings (TTM)
- Not reported
- Price / book
- 0.33
The source values and product destination above identify the example to inspect.
What business is this, and what does its dated valuation mean?
Check the market day first. P/E uses trailing earnings; book value and market capitalization answer different questions.
Daily valuation dataset and column definitionsOpen the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research EMIS in the app
Open the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research EMIS in the appKeep reporting dates and units beside the answer, and inspect its original citations.
Company overview
Emisphere Technologies, Inc. operates as a commercial stage pharmaceutical and drug delivery company in the United States. The company offers oral Eligen B12 Rx, an oral formulation prescription medical food for use by B12 deficient individuals. It is also developing GLP-1, which is in Phase III clinical trial for the treatment of type 2 diabetes and related conditions. The company's preclinical programs focus on the development of oral formulations for the treatment of diabetes; and products in the areas of cardiovascular, appetite suppression, and pain, as well as in the development and expansion of nutritional supplement products. It has license agreements with Novo Nordisk A/S to develop and commercialize oral formulations of GLP-1 receptor agonists in combination with Emisphere carriers, as well as to develop and commercialize oral formulations of Novo Nordisk's insulin using the company's Eligen Technology. The company was formerly known as Clinical Technologies Associates, Inc. and changed its name to Emisphere Technologies, Inc. in 1991. Emisphere Technologies, Inc. was founded in 1986 and is based in Roseland, New Jersey.
Daily valuation snapshot
See the complete daily valuation snapshot
These values come from the daily market snapshot dated 2026-09-25. TTM means trailing twelve months. Use the market date when comparing EMIS with another company.
Scroll sideways to compare all columns. Select a heading to sort.
| Daily close (USD) | $10.27 |
| Market capitalization (USD) | $39,368,329.91 |
| Price / earnings (TTM) | Not reported |
| Price / book | 0.33 |
No matching rows. Clear the filter to see all records.
Read EMIS's valuation metrics
Company size
Emmis Acquisition Corp. Class A Ordinary Shares's recorded market capitalization is $39,368,329.91. It measures the market value of the company's equity, rather than its revenue or cash balance.
Price relative to earnings
P/E compares share price with trailing annual earnings per share. For a company with losses, inspect the earnings figures directly rather than treating a negative multiple as a cheap valuation.
Price relative to book equity
EMIS's recorded price-to-book ratio is 0.33. That compares its market equity value with recorded book equity. Examine its business and balance sheet to understand why those values differ.
Research Emmis Acquisition Corp. Class A Ordinary Shares with Aurora
Use the snapshot above to ask a specific question about EMIS. Ask for the report period and the figures behind the explanation, then compare the answer with the company's business description.
Continue the research
Follow EMIS's ownership disclosures to see who filed a transaction or position and when it became public. To turn a research idea into a strategy, define an entry rule and test its dated observations.